Focusing on the development and industrialization of nucleic acid medicines
Focusing on the development and industrialization of nucleic acid medicines
Possesses a proprietary RNA-based Therapeutic Platform (RTP) independently developed for nucleic acid medicines

RongCan Biotech Has Cooperated with the School of Pharmacy at Shanghai Jiao Tong University to Establish a Joint Research Centre

Date : 2021-09-07